English  |  正體中文  |  简体中文  |  2826201  
???header.visitor??? :  31823361    ???header.onlineuser??? :  1268
???header.sponsordeclaration???
 
臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)
???ui.leftmenu.abouttair???

???ui.leftmenu.bartitle???

???index.news???

???ui.leftmenu.copyrighttitle???

???ui.leftmenu.link???

"sheng kai liang"???jsp.browse.items-by-author.description???

???jsp.browse.items-by-author.back???
???jsp.browse.items-by-author.order1??? ???jsp.browse.items-by-author.order2???

Showing items 41-65 of 72  (3 Page(s) Totally)
<< < 1 2 3 > >>
View [10|25|50] records per page

Institution Date Title Author
臺大學術典藏 2021-01-08T03:40:22Z Otitis media and otomastoiditis caused by Mycobacterium massiliense (Mycobacterium abscessus subsp. bolletii) Hsueh P.-R.; Lee L.-N.; SHENG-KAI LIANG; Liao C.-H.; Huang Y.-T.; Lee M.-R.; Tsai H.-Y.; Cheng A.; Liu C.-Y.
臺大學術典藏 2021-01-08T03:40:21Z Vorinostat enhances the cisplatin-mediated anticancer effects in small cell lung cancer cells Pan C.-H.; Chang Y.-F.; Lee M.-S.; Wen B.-C.; Ko J.-C.; SHENG-KAI LIANG; Liang M.-C.
臺大學術典藏 2021-01-08T03:40:21Z Bacteraemia caused by Mycobacterium abscessus subsp. abscessus and M. abscessus subsp. bolletii: Clinical features and susceptibilities of the isolates Lee M.-R.; Ko J.-C.; SHENG-KAI LIANG; Lee S.-W.; Yen D.H.-T.; Hsueh P.-R.
臺大學術典藏 2021-01-08T03:40:21Z Evaluating pleural ADA, ADA2, IFN-γ and IGRA for diagnosing tuberculous pleurisy SHENG-KAI LIANG; Chen J.Y.P.; Shu C.-C.; Keng L.-T.; Lin C.-K.; Chang L.-Y.; Chang C.-H.; Wang J.-Y.; Yu C.-J.; Lee L.-N.
臺大學術典藏 2021-01-08T03:40:21Z Clinical characteristics of bacteraemia caused by Lactobacillus spp. and antimicrobial susceptibilities of the isolates at a medical centre in Taiwan, 2000-2014 Lee M.-R.; Tsai C.-J.; SHENG-KAI LIANG; Lin C.-K.; Huang Y.-T.; Hsueh P.-R.
臺大學術典藏 2021-01-08T03:40:20Z Foxm1 Transcription Factor Regulates Lung Adenocarcinoma Development SHENG-KAI LIANG; Chao S.-Y.; Li C.-C.; Ip K.-U.; Lin Y.-K.; Hsu C.-C.; Hsu P.-C.; Wang I.-C.
臺大學術典藏 2021-01-08T03:40:20Z Prognostic factors of afatinib as a first-line therapy for advanced EGFR mutation-positive lung adenocarcinoma: A real-world, large cohort study Shih J.-Y.; Ko J.-C.; Ho C.-C.; Liao W.-Y.; Lee M.-R.; SHENG-KAI LIANG
臺大學術典藏 2021-01-08T03:40:20Z Significant clinical factors associated with long-term mortality in critical cancer patients requiring prolonged mechanical ventilation Wang H.-C.; Hsu C.-L.; Jerng J.-S.; Chen Y.-F.; Chang H.-T.; Chen I.-C.; Cheng J.-C.; SHENG-KAI LIANG; Lin S.-Y.; Keng L.-T.; Chung K.-P.; Kuo P.-H.; Wu H.-D.; Shih J.-Y.; Yu C.-J.
臺大學術典藏 2021-01-08T03:40:20Z Real-world experience of afatinib as a first-line therapy for advanced EGFR mutation-positive lung adenocarcinoma Shih J.-Y.; Ko J.-C.; Lee M.-R.; Keng L.-T.; Hsieh M.-S.; SHENG-KAI LIANG
臺大學術典藏 2021-01-08T03:40:19Z Pulmonary granulomas: Give it a whorl Keng L.-T.; Lo W.-Y.; Huang H.-N.; Ko H.-J.; SHENG-KAI LIANG
臺大學術典藏 2021-01-08T03:40:19Z Afatinib is effective in the treatment of lung adenocarcinoma with uncommon EGFR p.L747P and p.L747S mutations SHENG-KAI LIANG; Ko J.-C.; Yang J.C.-H.; Shih J.-Y.
臺大學術典藏 2021-01-08T03:40:19Z Albers-Sch?nberg disease Keng L.-T.; SHENG-KAI LIANG
臺大學術典藏 2021-01-08T03:40:18Z Predicting lung cancer occurrence in never-smoking females in Asia: TNSF-SQ, a prediction model Chien L.-H.; Chen C.-H.; Chen T.-Y.; Chang G.-C.; Tsai Y.-H.; Hsiao C.-F.; Chen K.-Y.; Su W.-C.; Wang W.-C.; Huang M.-S.; Chen Y.-M.; Chen C.-Y.; SHENG-KAI LIANG; Chen C.-Y.; Wang C.-L.; Lee M.-H.; Chung R.-H.; Tsai F.-Y.; Hu J.-W.; Katki H.A.; Chatterjee N.; Chanock S.J.; Rothman N.; Lan Q.; Yang P.-C.; Chen C.-J.; Chang I.-S.; Hsiung C.A.
臺大學術典藏 2021-01-08T02:56:47Z Bronchial atresia Li-Ta Keng;Liang S.-K.; LI-TA KENG; SHENG-KAI LIANG
臺大學術典藏 2021-01-08T02:56:46Z Significant clinical factors associated with long-term mortality in critical cancer patients requiring prolonged mechanical ventilation Yen-Fu Chen; I-Chun Chen; Jui-Chen Cheng; SHENG-KAI LIANG; Shu-Yung Lin; Li-Ta Keng;Chung K.-P.;Lin S.-Y.;Liang S.-K.;Cheng J.-C.;Chen I.-C.;Chen Y.-F.;Chang H.-T.;Hsu C.-L.;Jerng J.-S.;Wang H.-C.;Kuo P.-H.;Wu H.-D.;Shih J.-Y.;Yu C.-J.; LI-TA KENG; Kuei-Pin Chung; Hou-Tai Chang; Chia-Lin Hsu; Jih-Shuin Jerng; Hao-Chien Wang; Ping-Hung Kuo; Huey-Dong Wu; Jin-Yuan Shih; Chong-Jen Yu
臺大學術典藏 2021-01-08T02:56:45Z Albers-Schönberg disease SHENG-KAI LIANG; LI-TA KENG; Li-Ta Keng;Liang S.-K.
臺大學術典藏 2019-12-23T03:27:21Z Albers-Schonberg disease SHENG KAI LIANG;LI-TA KENG; LI-TA KENG; SHENG KAI LIANG
臺大學術典藏 2019-12-23T03:27:21Z Albers-Schonberg disease SHENG KAI LIANG;LI-TA KENG; LI-TA KENG; SHENG KAI LIANG
臺大學術典藏 2019-12-18T06:15:22Z Afatinib is effective in the treatment of lung adenocarcinoma with uncommon EGFR p.L747P and p.L747S mutations Yang, James Chih-Hsin; Shih, Jin-Yuan;SHENG KAI LIANG;JEN-CHUNG KO; JEN-CHUNG KO; SHENG KAI LIANG; Yang, James Chih-Hsin; Shih, Jin-Yuan
臺大學術典藏 2019-12-18T06:15:22Z Afatinib is effective in the treatment of lung adenocarcinoma with uncommon EGFR p.L747P and p.L747S mutations Yang, James Chih-Hsin; Shih, Jin-Yuan;SHENG KAI LIANG;JEN-CHUNG KO; JEN-CHUNG KO; SHENG KAI LIANG; Yang, James Chih-Hsin; Shih, Jin-Yuan
臺大學術典藏 2019-03-04T08:06:47Z Prognostic factors of afatinib as a first-line therapy for advanced EGFR mutation-positive lung adenocarcinoma: a real-world, large cohort study Sheng-Kai Liang;Meng-Rui Lee;Wei-Yu Liao;Chao-Chi Ho;Jen-Chung Ko;Jin-Yuan Shih; SHENG-KAI LIANG; MENG-RUI LEE; WEI-YU LIAO; CHAO-CHI HO; JEN-CHUNG KO; JIN-YUAN SHIH
臺大學術典藏 2019-03-04T08:06:47Z Prognostic factors of afatinib as a first-line therapy for advanced EGFR mutation-positive lung adenocarcinoma: a real-world, large cohort study Sheng-Kai Liang;Meng-Rui Lee;Wei-Yu Liao;Chao-Chi Ho;Jen-Chung Ko;Jin-Yuan Shih; SHENG-KAI LIANG; MENG-RUI LEE; WEI-YU LIAO; CHAO-CHI HO; JEN-CHUNG KO; JIN-YUAN SHIH
臺大學術典藏 2018-09-10T18:07:07Z Prognostic factors of afatinib as a first-line therapy for advanced EGFR mutation-positive lung adenocarcinoma: A real-world, large cohort study Liang, S.-K. and Lee, M.-R. and Liao, W.-Y. and Ho, C.-C. and Ko, J.-C. and Shih, J.-Y.; MENG RUI LEE; Wei-Yu Liao; Chao-Chi Ho; Jin-Yuan Shih; JEN-CHUNG KO; SHENG-KAI LIANG
臺大學術典藏 2018-09-10T18:06:04Z Real-world experience of afatinib as a first-line therapy for advanced EGFR mutation-positive lung adenocarcinoma Liang, S.-K. and Hsieh, M.-S. and Lee, M.-R. and Keng, L.-T. and Ko, J.-C. and Shih, J.-Y.; MENG-RUI LEE; KENG LI-TA; JEN-CHUNG KO; SHENG-KAI LIANG; JIN-YUAN SHIH
臺大學術典藏 2018-09-10T18:06:04Z Significant Clinical Factors Associated with Long-term Mortality in Critical Cancer Patients Requiring Prolonged Mechanical Ventilation. JIN-YUAN SHIH; Li-Ta Keng, Kuei-Pin Chung, Shu-Yung Lin, Sheng-Kai Liang, Jui-Chen Cheng, I-Chun Chen, Yen-Fu Chen, Hou-Tai Chang, Chia-Lin Hsu, Jih-Shuin Jerng, Hao-Chien Wang, Ping-Hung Kuo, Huey-Dong Wu, Jin-Yuan Shih, Chong-Jen Yu; PING-HUNG KUO; JIH-SHUIN JERNG; Chong-Jen Yu; HAO-CHIEN WANG; CHIA-LIN HSU; KUEI-PIN CHUNG; KENG LI-TA; SHENG-KAI LIANG

Showing items 41-65 of 72  (3 Page(s) Totally)
<< < 1 2 3 > >>
View [10|25|50] records per page